Skip to main content

Research Repository

Advanced Search

Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer

Taylor, Kathryn M.; Green, Andrew R.; Ellis, Ian O.; Gee, Julia M. W.; Ziliotto, Silvia; Zilio, Silvia; Gee, Julia M W; Ellis, Ian O; Green, Andrew R; Finlay, Pauline; Gobbato, Anna; Taylor, Kathryn M

Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer Thumbnail


Authors

Kathryn M. Taylor

Andrew R. Green

Ian O. Ellis

Julia M. W. Gee

Silvia Ziliotto

Silvia Zilio

Julia M W Gee

Pauline Finlay

Anna Gobbato

Kathryn M Taylor



Abstract

ZIP7, a member of the ZIP family of zinc importers, resides on the endoplasmic reticulum membrane and transports zinc from intracellular stores to the cytoplasm after activation by CK2 phosphorylation on two serine residues (S275 and S276). ZIP7 is known to be required for the growth of anti-hormone resistant breast cancer models, especially acquired tamoxifen-resistant cells developed from MCF-7. Using our new pS275S276ZIP7 antibody which only recognises activated ZIP7 (pZIP7), we have demonstrated that the hyperactivation of ZIP7 is prevalent in tamoxifen-resistant breast cancer cells. This evidence suggests that pZIP7 might have potential as a biomarker of acquired resistance to such anti-hormones in breast cancer, a current unmet clinical need. In this regard, we have also developed a new immunohistochemical assay for pZIP7 which allowed pZIP7 to be tested on a small clinical series of breast cancer tissues confirming its prevalence in such tumours and relationship to a variety of clinicopathological parameters and biomarkers previously associated with endocrine resistant phenotypes, notably increased activated MAPK signalling, expression of ErbB2, CD71 and the proto-oncogene c-Fos, as well as with increased tumour grade.

Citation

Taylor, K. M., Green, A. R., Ellis, I. O., Gee, J. M. W., Ziliotto, S., Zilio, S., …Taylor, K. M. (2019). Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer. Metallomics, 11(9), 1579-1592. https://doi.org/10.1039/c9mt00136k

Journal Article Type Article
Acceptance Date Jul 22, 2019
Online Publication Date Sep 4, 2019
Publication Date Sep 4, 2019
Deposit Date Sep 13, 2019
Publicly Available Date Sep 13, 2019
Journal Metallomics
Print ISSN 1756-5901
Electronic ISSN 1756-591X
Publisher Royal Society of Chemistry
Peer Reviewed Peer Reviewed
Volume 11
Issue 9
Pages 1579-1592
DOI https://doi.org/10.1039/c9mt00136k
Keywords Biophysics; Biochemistry; Chemistry (miscellaneous); Metals and Alloys; Biomaterials
Public URL https://nottingham-repository.worktribe.com/output/2611911
Publisher URL https://pubs.rsc.org/en/content/articlelanding/2019/MT/C9MT00136K#!divAbstract
Additional Information : This document is Similarity Check deposited; : Silvia Ziliotto (ORCID); : Kathryn M. Taylor (ORCID); : Kathryn M. Taylor (ResearcherID); : Single-blind; : Received 24 May 2019; Accepted 22 July 2019; Advance Article published 4 September 2019; Version of Record published 18 September 2019

Files





You might also like



Downloadable Citations